2002
DOI: 10.1177/120347540200600309
|View full text |Cite
|
Sign up to set email alerts
|

Arachidonic Acid-Derived Bioactive Lipids: Their Role and the Role for Their Inhibitors in Dermatology

Abstract: Newer drug discovery methods, including combinatorial chemistry with molecular modeling, have made it possible to develop inhibitors and analogs with increasing specificity and bioactivity and decreasing toxicity. Although the application of these analogs and inhibitors for cutaneous disease is limited today, either as primary agents or adjuvant therapy, these drugs will have a place in our therapeutic regimes of the future. We present a review of the therapeutic agents now available from manipulation of these… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
3
0

Year Published

2002
2002
2012
2012

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 138 publications
(53 reference statements)
0
3
0
Order By: Relevance
“…Prostaglandins are lipid‐derived mediators that have a wide spectrum of biological activities that is determined by their tissue of origin [1,2]. In the skin they mediate inflammatory reactions, although the sequence of events involved in these responses is poorly understood.…”
Section: Introductionmentioning
confidence: 99%
“…Prostaglandins are lipid‐derived mediators that have a wide spectrum of biological activities that is determined by their tissue of origin [1,2]. In the skin they mediate inflammatory reactions, although the sequence of events involved in these responses is poorly understood.…”
Section: Introductionmentioning
confidence: 99%
“…Leukotrienes are proinflammatory lipids implicated in the pathogenesis of inflammation-driven diseases, including asthma, atopic dermatitis, reperfusion injury, immediate hypersensitivity reactions, adaptive immune responses, rheumatoid arthritis, inflammatory bowel disease, and psoriasis (1,2). Leukotriene B4 (LTB4) mediates innate immune responses by modulating leukocyte effector functions and production of chemokines and cytokines that amplify inflammation (3).…”
mentioning
confidence: 99%
“…Metabolic inactivation of leukotriene signaling has been ignored as a proresolving mechanism due to the dearth of knowledge concerning how catabolic pathways are regulated, especially in peripheral tissues afflicted in common inflammatory diseases. The potent chemoattractant LTB4 is inactivated mainly by hydroxylation at the -terminus, catalyzed by cytochromes P450 CYP4F3A and CYP4F2 (CYP gene products) in human neutrophils and liver, respectively (2,6,7). Proresolving actions of CYP4F enzymes are further supported by their increased expression in various organ systems following traumatic brain injury or challenge with proinflammatory mediators (6,8,9).…”
mentioning
confidence: 99%